CAMBRIDGE, Mass., Nov 05, 2008 (BUSINESS WIRE) -- Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its financial results for the third quarter ended September 30, 2008.

"Helicos continues to make important strides in key aspects of our business aimed at building our commercial momentum," said Steve Lombardi, Helicos president and chief executive officer. "We believe the scientific capability available at our initial specifications, validated on our system in the third quarter, provides unique value to scientists as they scale their experiments and delve deeper into the biology of the cell in translational research."